tiprankstipranks
Trending News
More News >
American Healthcare REIT, Inc. (AHR)
NYSE:AHR
US Market
Advertisement

American Healthcare REIT, Inc. (AHR) AI Stock Analysis

Compare
205 Followers

Top Page

AHR

American Healthcare REIT, Inc.

(NYSE:AHR)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
$52.00
▲(2.40% Upside)
American Healthcare REIT, Inc. shows strong earnings call performance with significant growth and improved guidance, which is the most significant factor driving the score. Technical analysis supports a bullish trend, though valuation concerns due to a high P/E ratio temper the outlook. Financial performance is stable but highlights the need for improved profitability.
Positive Factors
Revenue Growth
Consistent same-store NOI growth indicates strong demand for AHR's properties, enhancing revenue stability and supporting long-term growth.
Acquisition Strategy
Strategic acquisitions and partnerships expand AHR's portfolio and geographic reach, strengthening its market position and growth potential.
Debt Management
Improved debt metrics enhance financial flexibility, reducing risk and supporting future investment opportunities and growth initiatives.
Negative Factors
Profitability Concerns
Low profitability limits reinvestment capacity and shareholder returns, posing a challenge to sustainable growth and financial health.
Medicare Rate Growth Challenges
Slower Medicare rate growth could impact revenue from healthcare facilities, affecting AHR's ability to maintain its growth trajectory.
Seasonality Impact
Potential seasonal impacts on occupancy could affect revenue consistency, posing a risk to maintaining growth momentum in the short term.

American Healthcare REIT, Inc. (AHR) vs. SPDR S&P 500 ETF (SPY)

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company DescriptionFormed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
How the Company Makes MoneyAmerican Healthcare REIT generates revenue primarily through rental income from its portfolio of healthcare properties. The company enters into long-term lease agreements with operators of senior living facilities, skilled nursing homes, and medical offices, which provides a steady stream of rental payments. Additionally, AHR may earn revenue from property management services and potential capital appreciation of its real estate assets. The company's revenue model is supported by strategic partnerships with established healthcare operators, which enhances its ability to secure long-term leases and ensures that its properties are well-managed and occupied. Market demand for healthcare services and demographic trends, such as an aging population, further contribute to AHR's revenue stability and growth prospects.

American Healthcare REIT, Inc. Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 19, 2026
Earnings Call Sentiment Positive
The earnings call reflected a strong performance with significant growth in same-store NOI and successful acquisition strategies. The company improved its debt metrics and increased guidance for 2025. However, growth headwinds from slower Medicare rate increases and potential seasonal impacts were noted.
Q3-2025 Updates
Positive Updates
Strong Same-Store NOI Growth
American Healthcare REIT reported a 16.4% same-store NOI growth across the total portfolio, marking the seventh consecutive quarter of double-digit same-store NOI growth.
Successful Acquisitions and Partnerships
Year-to-date, the company closed over $575 million in acquisitions within their RIDEA segments and introduced two new relationships with operators to broaden geographic diversification.
Normalized FFO Growth
The company is on track to grow normalized FFO per fully diluted share by 20% over the previous year.
Debt Reduction
Net debt to EBITDA at the end of the third quarter decreased to 3.5x.
Increased 2025 Guidance
Increased and narrowed full-year 2025 NFFO guidance to a range of $1.69 to $1.72 from $1.64 to $1.68 per fully diluted share.
Negative Updates
Challenges in Medicare Rate Growth
Medicare national rate growth slowed to 3.2% compared to over 6% in the previous year, presenting a growth headwind for Q4.
Potential Seasonality Impact
Occupancy trends into the fourth quarter suggest that seasonality could be muted, presenting potential challenges in maintaining momentum.
Company Guidance
During the American Healthcare REIT Q3 2025 Earnings Conference Call, the company provided updated guidance reflecting strong performance and strategic growth. The company reported a 16.4% same-store NOI growth across its total portfolio, marking its seventh consecutive quarter of double-digit growth. President and CEO Danny Prosky highlighted the success of the RIDEA structured segments, including Trilogy and SHOP, which have driven significant growth. Trilogy's same-store NOI grew by 21.7% year-over-year, with occupancy averaging 90.2%, and SHOP's NOI increased by 25.3%. The company has closed on over $575 million in acquisitions year-to-date, with a pipeline of over $450 million expected to close by early 2026. They are on track to grow normalized FFO per fully diluted share by 20% over the previous year. The net debt to EBITDA ratio improved to 3.5x by the end of the third quarter. The company also increased its full-year 2025 NFFO guidance range to $1.69 to $1.72 per fully diluted share, driven by strong occupancy and organic growth expectations.

American Healthcare REIT, Inc. Financial Statement Overview

Summary
American Healthcare REIT, Inc. demonstrates a mixed financial performance. Revenue growth is steady, and cash flow metrics are strong, indicating good operational cash management. However, profitability remains a concern with negative net income and return on equity. The company has improved its leverage position, but further efforts are needed to enhance profitability and shareholder returns.
Income Statement
65
Positive
The income statement shows a mixed performance. The TTM revenue growth rate is positive at 1.8%, indicating a steady increase in revenue. However, the company is struggling with profitability, as evidenced by a negative net profit margin of -1.53% and a negative net income. The gross profit margin has improved significantly to 39.85% in the TTM, suggesting better cost management. EBIT and EBITDA margins are moderate, indicating operational efficiency but not translating into net profitability.
Balance Sheet
58
Neutral
The balance sheet reflects a moderate financial position. The debt-to-equity ratio has improved to 0.66 in the TTM, indicating a reduction in leverage compared to previous years. However, the return on equity remains negative at -1.43%, highlighting ongoing profitability challenges. The equity ratio is stable, suggesting a balanced asset structure, but the company needs to improve its return metrics to enhance shareholder value.
Cash Flow
72
Positive
Cash flow analysis shows positive trends, with a strong free cash flow growth rate of 34.63% in the TTM, indicating improved cash generation capabilities. The operating cash flow to net income ratio is high at 0.93, suggesting efficient cash conversion from operations. The free cash flow to net income ratio is also robust at 0.79, reflecting good cash flow management despite negative net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.20B2.07B1.86B1.62B1.26B1.18B
Gross Profit454.97M416.77M356.83M335.97M182.01M158.58M
EBITDA292.57M315.48M324.26M233.76M159.43M165.14M
Net Income27.26M-37.81M-71.47M-81.30M-47.79M2.16M
Balance Sheet
Total Assets4.77B4.49B4.58B4.79B4.58B3.23B
Cash, Cash Equivalents and Short-Term Investments147.36M76.70M43.45M65.05M81.60M113.21M
Total Debt1.70B1.87B3.02B2.83B2.50B1.88B
Total Liabilities2.05B2.18B3.12B3.14B2.75B2.16B
Stockholders Equity2.68B2.26B1.27B1.40B1.58B866.11M
Cash Flow
Free Cash Flow269.10M84.15M-1.26M76.25M-61.78M90.85M
Operating Cash Flow298.79M176.09M98.53M147.77M17.91M219.16M
Investing Cash Flow-286.11M-8.73M9.40M-118.58M-138.65M-147.94M
Financing Cash Flow55.06M-134.74M-129.06M-42.92M94.11M-8.81M

American Healthcare REIT, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price50.78
Price Trends
50DMA
44.72
Positive
100DMA
42.41
Positive
200DMA
37.04
Positive
Market Momentum
MACD
1.48
Negative
RSI
71.01
Negative
STOCH
76.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 50.78 is above the 20-day moving average (MA) of 48.35, above the 50-day MA of 44.72, and above the 200-day MA of 37.04, indicating a bullish trend. The MACD of 1.48 indicates Negative momentum. The RSI at 71.01 is Negative, neither overbought nor oversold. The STOCH value of 76.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Risk Analysis

American Healthcare REIT, Inc. disclosed 79 risk factors in its most recent earnings report. American Healthcare REIT, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

American Healthcare REIT, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$8.36B27.908.13%3.45%59.25%88.37%
77
Outperform
$3.79B25.0510.87%4.81%8.04%9.20%
76
Outperform
$13.57B25.8011.28%5.84%13.50%31.56%
74
Outperform
$4.86B26.836.29%6.15%8.12%75.95%
68
Neutral
$9.52B360.651.12%1.97%11.81%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
57
Neutral
$6.41B-7.26%6.03%-6.59%33.35%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AHR
American Healthcare REIT, Inc.
50.78
22.68
80.71%
NHI
National Health Investors
79.48
6.84
9.42%
OHI
Omega Healthcare
45.92
8.77
23.61%
SBRA
Sabra Healthcare REIT
19.51
2.06
11.81%
HR
Healthcare Realty Trust
18.23
0.88
5.07%
CTRE
CareTrust REIT
37.53
9.60
34.37%

American Healthcare REIT, Inc. Corporate Events

American Healthcare REIT Reports Robust Earnings Growth
Nov 9, 2025

The latest earnings call from American Healthcare REIT, Inc. painted a picture of robust performance and strategic growth, despite some anticipated challenges. The company reported significant growth in same-store NOI and highlighted successful acquisition strategies. Improvements in debt metrics and an increased guidance for 2025 were also key takeaways. However, the company acknowledged potential growth headwinds from slower Medicare rate increases and possible seasonal impacts.

American Healthcare REIT, Inc. Reports Strong Q3 2025 Results
Nov 8, 2025

American Healthcare REIT, Inc. is a real estate investment trust that acquires, owns, and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, the United Kingdom, and the Isle of Man.

Business Operations and StrategyFinancial Disclosures
American Healthcare REIT Reports Strong Q3 2025 Results
Positive
Nov 6, 2025

On November 6, 2025, American Healthcare REIT, Inc. announced its third quarter 2025 results, highlighting a GAAP net income of $55.9 million and a 16.4% growth in Same-Store Net Operating Income compared to the same period in 2024. The company also reported significant acquisition activity, closing over $575 million in new acquisitions year-to-date, and increased its full-year 2025 guidance due to strong performance in its senior housing and integrated senior health campuses segments. The announcement reflects the company’s strategic growth and favorable market conditions, positioning it well for continued expansion and stakeholder value enhancement.

The most recent analyst rating on (AHR) stock is a Hold with a $51.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Dividends
American Healthcare REIT Announces Quarterly Distribution
Positive
Sep 18, 2025

On September 18, 2025, American Healthcare REIT, Inc. announced a quarterly distribution of $0.25 per share for the third quarter of 2025, covering the period from July 1 to September 30. This distribution, equating to an annualized rate of $1.00 per share, will be paid in cash on or about October 17, 2025, to stockholders of record as of September 30, 2025. This announcement reflects the company’s ongoing commitment to providing returns to its investors and may influence its market positioning within the healthcare real estate sector.

The most recent analyst rating on (AHR) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

American Healthcare REIT Reports Strong Earnings Call
Aug 13, 2025

American Healthcare REIT, Inc. recently held its earnings call, revealing a generally positive sentiment characterized by strong financial performance. The company reported significant same-store NOI growth, successful acquisitions, and improved leverage metrics. Noteworthy achievements include obtaining the Great Place to Work Certification and increasing Medicare Advantage concentration. Despite these positives, challenges were noted in the outpatient medical segment and the complexities of navigating fragmented Medicare Advantage contracts. Overall, the positive aspects of the earnings call significantly outweighed the challenges.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 13, 2025